Recarbrio – which based on established antibiotic combination imipenem/cilastatin with Merck’s new beta-lactamase inhibitor relebactam – has been cleared by the FDA for adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback